Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome‐related inflammation and modulating cholesterol transport-Reference-Cited by-同舟云学术

Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome‐related inflammation and modulating cholesterol transport

Published:2019-12 Issue:1 Volume:34 Page:1398-1411
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Luo Jinque¹,Wang Xiao¹,Jiang Xinhai¹,Liu Chao¹,Li Yongzhen¹,Han Xiaowan¹,Zuo Xuan¹,Li Yining¹,Li Ni¹²,Xu Yanni¹,Si Shuyi¹

Affiliation:

1. NHC Key Laboratory of Biotechnology of Antibiotics National Center for Screening Novel Microbial Drugs Institute of Medicinal Biotechnology Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. State Key Laboratory of Bioactive Substance and Function of Natural Medicines Institute of Materia Medica Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201900903RRR

Reference49 articles.

1. Progress and challenges in translating the biology of atherosclerosis

2. Inflammation in atherosclerosis

3. Immune and Inflammatory Mechanisms of Atherosclerosis